Longitudinal Patient Behavioral Data for Clinical Trials and RWE
Capture continuous treatment experience, burden, and adherence markers outside the clinical site. Standardized to LOINC and SNOMED CT for seamless regulatory submission.
Four ways to turn behavior into evidence.
Patient stratification & RWE
Identify clinically distinct subgroups across symptoms, behavior and self-report, with their full response trajectories, not just yes/no.
Journey mapping & unmet needs
Continuous monitoring of symptoms, quality of life and adherence reveals care gaps and evidence gaps over time.
HTA & market access
Complement clinical outcomes with longitudinal QoL, HCRU, PROs and digital phenotyping for stronger value demonstration.
PSP optimization
Find the behavioral signature behind adherence and design a targeted intervention for each root cause.
“Beyond a single average.”
Beyond a single average.
From methodology to evidence.
Design
We apply the methodology to your study population or cohort.
Capture
Multimodal behavioral data, structured to FHIR / SNOMED / LOINC.
Evidence
Exploratory or secondary endpoints and publication-ready datasets.
From Clinical Trials to Post-Market Value
In Clinical Development
Reduce participant drop-out rate and collect robust digital endpoints.
In Commercial Strategy
Deploy 'Beyond-the-Pill' support platforms that prove therapy value to payers and improve persistence.
Why patients and caregivers stay involved.
Meaningful value in exchange for continuous participation, which means richer longitudinal data.
Education
trusted, personalized information about disease and treatment
Easy reporting
voice, text, images or short questionnaires, low burden
Caregiver support
proxy reporting and guidance for elderly or paediatric patients
